Literature DB >> 26414679

Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.

Dallin Hubbard1,2, Michael Enda3, Tanner Bond4, Seyyed Pouya Hadipour Moghaddam1,5, Josh Conarton2, Courtney Scaife6, Eric Volckmann6, Hamidreza Ghandehari1,2,5.   

Abstract

Poly(amido amine) (PAMAM) dendrimers have shown transepithelial transport across intestinal epithelial barrier in rats and across Caco-2 cell monolayers. Caco-2 models innately lack mucous barriers, and rat isolated intestinal tissue has been shown to overestimate human permeability. This study is the first report of transport of PAMAM dendrimers across isolated human intestinal epithelium. It was observed that FITC labeled G4-NH2 and G3.5-COOH PAMAM dendrimers at 1 mM concentration do not have a statistically higher permeability compared to free FITC controls in isolated human jejunum and colonic tissues. Mannitol permeability was increased at 10 mM concentrations of G3.5-COOH and G4-NH2 dendrimers. Significant histological changes in human colonic and jejunal tissues were observed at G3.5-COOH and G4-NH2 concentrations of 10 mM implying that dose limiting toxicity may occur at similar concentrations in vivo. The permeability through human isolated intestinal tissue in this study was compared to previous rat and Caco-2 permeability data. This study implicates that PAMAM dendrimer oral drug delivery may be feasible, but it may be limited to highly potent drugs.

Entities:  

Keywords:  Ussing chambers; human intestinal mucosae; oral drug delivery; poly(amido amine) dendrimers; toxicity; transport

Mesh:

Substances:

Year:  2015        PMID: 26414679     DOI: 10.1021/acs.molpharmaceut.5b00541

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

Review 1.  Poly(amido amine) dendrimers in oral delivery.

Authors:  Venkata K Yellepeddi; Hamidreza Ghandehari
Journal:  Tissue Barriers       Date:  2016-04-06

2.  Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat.

Authors:  Chengyun Yan; Jiwei Gu; Yuguang Lv; Weiguo Shi; Hongying Jing
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

Review 3.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

4.  Endocytic Uptake, Transport and Macromolecular Interactions of Anionic PAMAM Dendrimers within Lung Tissue.

Authors:  Christopher J Morris; Ghaith Aljayyoussi; Omar Mansour; Peter Griffiths; Mark Gumbleton
Journal:  Pharm Res       Date:  2017-06-14       Impact factor: 4.200

5.  Molecular dynamics simulations in drug delivery research: Calcium chelation of G3.5 PAMAM dendrimers.

Authors:  David E Jones; Albert M Lund; Hamidreza Ghandehari; Julio C Facelli
Journal:  Cogent Chem       Date:  2016-09-22

Review 6.  Use of Polyamidoamine Dendrimers in Brain Diseases.

Authors:  Maria Florendo; Alexander Figacz; Bhairavi Srinageshwar; Ajit Sharma; Douglas Swanson; Gary L Dunbar; Julien Rossignol
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.